The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Drug Discovery Informatics-Global Market Insights and Sales Trends 2024

Drug Discovery Informatics-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1820060

No of Pages : 102

Ask Your Query

Synopsis

The global Drug Discovery Informatics market size is expected to reach US$ 1 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Discovery Informatics in various end use industries.

The expanding demands from the Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Others,, are propelling Drug Discovery Informatics market. Software, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Discovery Informatics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Drug Discovery Informatics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Drug Discovery Informatics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Discovery Informatics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Drug Discovery Informatics covered in this report include IBM, Infosys, Thermo Fisher Scientific, Perkinelmer, Schrödinger, Dassault Systèmes, Charles River Laboratories, Selvita and Certara, etc.

The global Drug Discovery Informatics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • IBM
  • Infosys
  • Thermo Fisher Scientific
  • Perkinelmer
  • Schrödinger
  • Dassault Systèmes
  • Charles River Laboratories
  • Selvita
  • Certara
  • GVK Biosciences
  • Collaborative Drug Discovery
  • Openeye Scientific Software
  • IO Informatics
  • Novo Informatics

Global Drug Discovery Informatics market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Drug Discovery Informatics market, Segment by Type:

  • Software
  • Services

Global Drug Discovery Informatics market, by Application

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Discovery Informatics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Drug Discovery Informatics
1.1 Drug Discovery Informatics Market Overview
1.1.1 Drug Discovery Informatics Product Scope
1.1.2 Drug Discovery Informatics Market Status and Outlook
1.2 Global Drug Discovery Informatics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug Discovery Informatics Market Size by Region (2018-2029)
1.4 Global Drug Discovery Informatics Historic Market Size by Region (2018-2023)
1.5 Global Drug Discovery Informatics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug Discovery Informatics Market Size (2018-2029)
1.6.1 North America Drug Discovery Informatics Market Size (2018-2029)
1.6.2 Europe Drug Discovery Informatics Market Size (2018-2029)
1.6.3 Asia-Pacific Drug Discovery Informatics Market Size (2018-2029)
1.6.4 Latin America Drug Discovery Informatics Market Size (2018-2029)
1.6.5 Middle East & Africa Drug Discovery Informatics Market Size (2018-2029)
2 Drug Discovery Informatics Market by Type
2.1 Introduction
2.1.1 Software
2.1.2 Services
2.2 Global Drug Discovery Informatics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug Discovery Informatics Historic Market Size by Type (2018-2023)
2.2.2 Global Drug Discovery Informatics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug Discovery Informatics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug Discovery Informatics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug Discovery Informatics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug Discovery Informatics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug Discovery Informatics Revenue Breakdown by Type (2018-2029)
3 Drug Discovery Informatics Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical & Biotechnology Companies
3.1.2 Contract Research Organizations (CROs)
3.1.3 Others
3.2 Global Drug Discovery Informatics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug Discovery Informatics Historic Market Size by Application (2018-2023)
3.2.2 Global Drug Discovery Informatics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug Discovery Informatics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug Discovery Informatics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug Discovery Informatics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug Discovery Informatics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug Discovery Informatics Revenue Breakdown by Application (2018-2029)
4 Drug Discovery Informatics Competition Analysis by Players
4.1 Global Drug Discovery Informatics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Discovery Informatics as of 2022)
4.3 Date of Key Players Enter into Drug Discovery Informatics Market
4.4 Global Top Players Drug Discovery Informatics Headquarters and Area Served
4.5 Key Players Drug Discovery Informatics Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Discovery Informatics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 IBM
5.1.1 IBM Profile
5.1.2 IBM Main Business
5.1.3 IBM Drug Discovery Informatics Products, Services and Solutions
5.1.4 IBM Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.1.5 IBM Recent Developments
5.2 Infosys
5.2.1 Infosys Profile
5.2.2 Infosys Main Business
5.2.3 Infosys Drug Discovery Informatics Products, Services and Solutions
5.2.4 Infosys Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.2.5 Infosys Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Drug Discovery Informatics Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.3.5 Perkinelmer Recent Developments
5.4 Perkinelmer
5.4.1 Perkinelmer Profile
5.4.2 Perkinelmer Main Business
5.4.3 Perkinelmer Drug Discovery Informatics Products, Services and Solutions
5.4.4 Perkinelmer Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.4.5 Perkinelmer Recent Developments
5.5 Schrödinger
5.5.1 Schrödinger Profile
5.5.2 Schrödinger Main Business
5.5.3 Schrödinger Drug Discovery Informatics Products, Services and Solutions
5.5.4 Schrödinger Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.5.5 Schrödinger Recent Developments
5.6 Dassault Systèmes
5.6.1 Dassault Systèmes Profile
5.6.2 Dassault Systèmes Main Business
5.6.3 Dassault Systèmes Drug Discovery Informatics Products, Services and Solutions
5.6.4 Dassault Systèmes Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.6.5 Dassault Systèmes Recent Developments
5.7 Charles River Laboratories
5.7.1 Charles River Laboratories Profile
5.7.2 Charles River Laboratories Main Business
5.7.3 Charles River Laboratories Drug Discovery Informatics Products, Services and Solutions
5.7.4 Charles River Laboratories Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.7.5 Charles River Laboratories Recent Developments
5.8 Selvita
5.8.1 Selvita Profile
5.8.2 Selvita Main Business
5.8.3 Selvita Drug Discovery Informatics Products, Services and Solutions
5.8.4 Selvita Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.8.5 Selvita Recent Developments
5.9 Certara
5.9.1 Certara Profile
5.9.2 Certara Main Business
5.9.3 Certara Drug Discovery Informatics Products, Services and Solutions
5.9.4 Certara Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.9.5 Certara Recent Developments
5.10 GVK Biosciences
5.10.1 GVK Biosciences Profile
5.10.2 GVK Biosciences Main Business
5.10.3 GVK Biosciences Drug Discovery Informatics Products, Services and Solutions
5.10.4 GVK Biosciences Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.10.5 GVK Biosciences Recent Developments
5.11 Collaborative Drug Discovery
5.11.1 Collaborative Drug Discovery Profile
5.11.2 Collaborative Drug Discovery Main Business
5.11.3 Collaborative Drug Discovery Drug Discovery Informatics Products, Services and Solutions
5.11.4 Collaborative Drug Discovery Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.11.5 Collaborative Drug Discovery Recent Developments
5.12 Openeye Scientific Software
5.12.1 Openeye Scientific Software Profile
5.12.2 Openeye Scientific Software Main Business
5.12.3 Openeye Scientific Software Drug Discovery Informatics Products, Services and Solutions
5.12.4 Openeye Scientific Software Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.12.5 Openeye Scientific Software Recent Developments
5.13 IO Informatics
5.13.1 IO Informatics Profile
5.13.2 IO Informatics Main Business
5.13.3 IO Informatics Drug Discovery Informatics Products, Services and Solutions
5.13.4 IO Informatics Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.13.5 IO Informatics Recent Developments
5.14 Novo Informatics
5.14.1 Novo Informatics Profile
5.14.2 Novo Informatics Main Business
5.14.3 Novo Informatics Drug Discovery Informatics Products, Services and Solutions
5.14.4 Novo Informatics Drug Discovery Informatics Revenue (US$ Million) & (2018-2023)
5.14.5 Novo Informatics Recent Developments
6 North America
6.1 North America Drug Discovery Informatics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug Discovery Informatics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Informatics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Discovery Informatics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Informatics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Discovery Informatics Market Dynamics
11.1 Drug Discovery Informatics Industry Trends
11.2 Drug Discovery Informatics Market Drivers
11.3 Drug Discovery Informatics Market Challenges
11.4 Drug Discovery Informatics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock